. 2003 Oct;71(10):5750–5755. doi: 10.1128/IAI.71.10.5750-5755.2003

TABLE 1.

Protection against B. abortus 544 provided to BALB/c mice by vaccination with rBLS and different adjuvant formulations

Treatment group (n = 8)	Vaccine	Log₁₀ brucellae CFU (mean ± SD) at:		Log protection at:
Treatment group (n = 8)	Vaccine	Spleen	Liver	Spleen	Liver
1	PBS	5.48 ± 0.13	2.45 ± 0.103	0	0
2	B. melitensis H38	3.21 ± 0.13	1.44 ± 0.136	2.27^a	1.01^a
3	BLS-PBS	5.11 ± 0.41	2.31 ± 0.298	0.37	0.14
4	BLS-IFA	4.23 ± 0.37	1.75 ± 0.299	1.26^a	0.70^a
5	BLS-MPA	4.17 ± 0.22	1.89 ± 0.482	1.31^a	0.56
6	BLS-Al	4.07 ± 0.22	1.43 ± 0.088	1.40^a	1.02^a
7	pcDNA-BLS	3.83 ± 0.48	1.50 ± 0.398	1.61^a	0.95^a

Significantly different (P < 0.01) compared with value for control (PBS-inoculated) mice.